首页|Role of cytokines and chemokines in non-alcoholic fatty liver disease

Role of cytokines and chemokines in non-alcoholic fatty liver disease

扫码查看
Non-alcoholic fatty liver disease (NAFLD) includes a variety of histological conditions (ranging from liver steatosis and steatohepatitis,to fibrosis and hepatocarcinoma) that are characterized by an increased fat content within the liver.The accumulation/deposition of fat within the liver is essential for diagnosis of NAFLD and might be associated with alterations in the hepatic and systemic inflammatory state.Although it is still unclear if each histological entity represents a different disease or rather steps of the same disease,inflammatory processes in NAFLD might influence its pathophysiology and prognosis.In particular,nonalcoholic steatohepatitis (the most inflamed condition in NAFLDs,which more frequently evolves towards chronic and serious liver diseases) is characterized by a marked activation of inflammatory cells and the upregulation of several soluble inflammatory mediators.Among several mediators,cytokines and chemokines might play a pivotal active role in NAFLD and are considered as potential therapeutic targets.In this review,we will update evidence from both basic research and clinical studies on the potential role of cytokines and chemokines in the pathophysiology of NAFLD.

InflammationNon-alcoholic fatty liver diseaseCytokineChemokine

Vincent Braunersreuther、Giorgio Luciano Viviani、Fran(c)ois Mach、Fabrizio Montecucco

展开 >

Division of Cardiology, Foundation for Medical Researches, Faculty of Medicine, Geneva University Hospital,1211 Geneva, Switzerland

Department of Internal Medicine,Adult Diabetes Centre, University of Genoa, 16143 Genoa, Italy

Swiss National Science Foundation"Sir Jules Thorn Trust Reg" FoundationGustave and Simone Prévot Foundation to Montecucco FEU FP7 AtheroRemoSwiss National Science FoundationNovartis Foundation and Swiss Heart Foundation to Mach F

32003B-134963/1201668310030B-133127

2012

世界胃肠病学杂志(英文版)
太原消化病研治中心

世界胃肠病学杂志(英文版)

SCI
影响因子:1.001
ISSN:1007-9327
年,卷(期):2012.18(8)
  • 26
  • 109